Abstract:Abstract Eight cyclic heptapeptides related to the full sequence of deltorphin have been synthesized. The synthesis of linear peptides containing diamino acid residues in positions 2 and 4 was carried out on a 4‐methylbenzhydrylamine resin. Depending on protection procedures, the N‐protected peptide‐resins or N‐protected peptide amides with free amino groups in the side chains were obtained, which were subsequently treated with bis‐(4‐nitrophenyl)carbonate to form a urea unit. Opioid activities of the peptides were determined in the guinea pig ileum (GPI) and mouse vas deferens (MVD) assays. Several compounds showed high δ opioid agonist potency and high selectivity for δ receptors. The results were compared with those obtained earlier for respective 1–4 deltorphin analogs. The conformations of these peptides have been studied using 2D‐NMR in H 2 O/D 2 O and molecular dynamics. We observed that the backbone rings had well defined conformations, while the Tyr and Phe side chains and the C ‐terminal tail had significant conformational freedom. The bioassay data and conformational parameters of these peptides were compared with those of previously described, corresponding 1–4 deltorphin analogs. This comparison permitted an assessment of the role of the C ‐terminal peptide segment in defining the conformation and receptor interaction of the N ‐terminal portion and provided insight into the relationship between the putative bioactive conformations and bioactivity. Copyright © 2008 European Peptide Society and John Wiley & Sons, Ltd.

Synthesis, Conformation And Opioid Activity Of Deltorphins

The Synthesis And 2d Nmr Study Of Deltorphins

Deltorphin analogs restricted via a urea bridge: structure and opioid activity

Structural Basis for Bifunctional Peptide Recognition at Human Δ-Opioid Receptor

Potent side-chain to side-chain cyclized dermorphin analogues containing a carbonyl bridge

Cyclic enkephalin-deltorphin hybrids containing a carbonyl bridge: structure and opioid activity.

Synthesis, Pharmacological Evaluation, and Computational Studies of Cyclic Opioid Peptidomimetics Containing β3-Lysine

Design, Synthesis and Functional Analysis of Cyclic Opioid Peptides with Dmt-Tic Pharmacophore

Design, Syntheses, and Pharmacological Characterization of 17-Cyclopropylmethyl-3,14 Beta-Dihydroxy-4,5 Alpha-Epoxy-6 Alpha-(Isoquinoline-3 '-Carboxamido)morphinan Analogues As Opioid Receptor Ligands

Synthesis and Biological Evaluations of Novel Endomorphin Analogues Containing Α-Hydroxy-β-phenylalanine (AHPBA) Displaying Mixed Μ/δ Opioid Receptor Agonist and Δ Opioid Receptor Antagonist Activities.

Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan analogues as opioid receptor ligands.

2',6'-dimethylphenylalanine (Dmp) can mimic the N-terminal Tyr in opioid peptides

Application of Bivalent Bioisostere Concept on Design and Discovery of Potent Opioid Receptor Modulators

Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors

Design, synthesis, and biological evaluation of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as μ opioid receptor selective Antagonists

Design, Synthesis, and In Vitro Characterization of Proteolytically-Stable Opioid-Neurotensin Hybrid Peptidomimetics

Design, synthesis, and pharmacological activities of dynorphin A analogues cyclized by ring-closing metathesis.

Synthesis and Evaluation of Κ-Opioid Receptor Agonistic Activity and Antinociceptive Effect of Novel Morphine Analogues, 7Α-Phenyl-6α,14α-endo-etheno-tetrahydrothebaine with Substituted O-, M- and P-Amino Group

Synthesis and Structure-Activity Relationships of 5'-Aryl-14-alkoxypyridomorphinans: Identification of a Mu Opioid Receptor Agonist/Delta Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects.

Verifying the role of 3-hydroxy of 17-cyclopropylmethyl-4,5-epoxy-3,14-dihydroxy-6-[(4-pyridyl) carboxamido]morphinan derivatives via their binding affinity and selectivity profiles on opioid receptors

14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: design, synthesis, and biological studies.